A cohort study of 12 patients with osteosarcoma revealed that the NOTCH1 signaling pathway was significantly upregulated in tumor tissues, and the high expression of the NOTCH1 intercellular domain (NICD1) and the NOTCH target gene Hes1 was associated with a poor response to chemotherapy [33]. The gene discussed is HES1; the disease is neoplasm.